The Advancing CGT Virtual Event presented by GENEWIZ and Brooks Life Sciences, opens on April 7-8, 2021 and aims to discuss the opportunities, challenges, and latest technology breakthroughs in cell and gene therapy.
| SOUTH PLAINFIELD, N.J., April 6, 2021 /PRNewswire/ -- The Advancing CGT Virtual Event presented by GENEWIZ and Brooks Life Sciences, opens on April 7-8, 2021 and aims to discuss the opportunities, challenges, and latest technology breakthroughs in cell and gene therapy. This free, 2-day meeting offers a platform for industry leaders and researchers from across the globe to present some of the latest research and solutions surrounding cell and gene therapy. Since the first approved gene therapy trial in 1990, interest in cell and gene therapies has increased rapidly, changing the course of research on disease prevention and treatment. However, there are still many challenges facing the field today, and further progress to be made in developing effective therapies. Attendees at the Advancing CGT Virtual Event will have the opportunity to learn more about various topics, such as developing AAV-based gene therapies, cold chain products and solutions for a wide range of materials, and more, as well as explore innovative solutions to accelerate the therapeutic development and safe delivery of successful cell and gene therapies. At the Advancing CGT Virtual Event, uncover the latest research from seven featured speakers: Lionel Galibert, Ph.D., Senior Scientist, Kuopio Center for Gene and Cell Therapy; Brian J. Hawkins, Ph.D., Chief Technology Officer, Pluristyx, Inc.; Elizabeth Louie, Ph.D., Supervisor, Technical Applications, GENEWIZ, A Brooks Life Sciences Company; Andrea O’Hara, Ph.D., Technical Application Scientist, GENEWIZ, A Brooks Life Sciences Company; Adriana Suarez, Ph.D., Science and Technology Advisor, 10x Genomics; Jude Samulski, Ph.D., President, Chief Scientific Officer and Co-Founder, AskBio; and Michael Weiand, Field Applications Manager, AMR East for Pacific Biosciences. Presentations will highlight subjects such as single-cell multiomics, cryopreservation, rAAV production using synthetic DNA, gene editing validation, and more. Event features include:
“As the global leader in genomics and sample storage, we are excited to present this forum for researchers to come together to discuss the challenges, opportunities, and recent advancements in the cell and gene therapy area,” stated Linda De Jesus, Senior Vice President and Chief Commercial Officer, Brooks Life Sciences. “Advancing CGT brings together a distinguished line-up of speakers including leading researchers and technology providers and we look forward to accelerating the conversation around cell and gene therapy technologies and solutions.” To view the complete agenda, including webinar abstracts and speaker biographies, and to register for free, click here. Use the official event hashtag #AdvCGT21 to join the conversation and stay up to date on the latest event information. About Brooks Life Sciences About LabRoots Media Contact: Melissa Fisher
SOURCE Brooks Life Sciences |
View original content to download multimedia:
